| GC30561-10mg |
|
137089-36-2 |
2-(E-2-decenoylamino)ethyl 2-(cyclohexylethyl) sulfide
|
0 |
C20H37NOS |
|
|
|
| GC30561-5mg |
|
137089-36-2 |
2-(E-2-decenoylamino)ethyl 2-(cyclohexylethyl) sulfide
|
0 |
C20H37NOS |
|
|
|
| GC30561-1mg |
|
137089-36-2 |
2-(E-2-decenoylamino)ethyl 2-(cyclohexylethyl) sulfide
|
0 |
C20H37NOS |
|
|
|
| GC30559-100mL |
|
8001-29-4 |
|
0 |
— |
|
|
|
| GC30558-10mg |
|
298202-25-2 |
|
0 |
C101H164N24O28S |
|
|
|
| GC30558-5mg |
|
298202-25-2 |
|
0 |
C101H164N24O28S |
|
|
|
| GC30558-1mg |
|
298202-25-2 |
|
0 |
C101H164N24O28S |
|
|
|
| GC30557-5g |
|
632-99-5 |
Fuchsine base monohydrochloride (Magenta base monohydrochloride)
|
0 |
C20H20ClN3 |
|
|
|
| GC30557-1g |
|
632-99-5 |
Fuchsine base monohydrochloride (Magenta base monohydrochloride)
|
0 |
C20H20ClN3 |
|
|
|
| GC30557-10mM(1mLinDMSO) |
|
632-99-5 |
Fuchsine base monohydrochloride (Magenta base monohydrochloride)
|
0 |
C20H20ClN3 |
|
|
|
| GC30556-10mg |
|
132996-61-3 |
Osteogenic Growth Peptide, OGP
|
0 |
C68H110N22O18 |
|
|
|
| GC30556-5mg |
|
132996-61-3 |
Osteogenic Growth Peptide, OGP
|
0 |
C68H110N22O18 |
|
|
|
| GC30556-1mg |
|
132996-61-3 |
Osteogenic Growth Peptide, OGP
|
0 |
C68H110N22O18 |
|
|
|
| GC30555-10mg |
|
643727-55-3 |
|
0 |
C18H16N2O6S |
|
|
|
| GC30555-5mg |
|
643727-55-3 |
|
0 |
C18H16N2O6S |
|
|
|
| GC30555-1mg |
|
643727-55-3 |
|
0 |
C18H16N2O6S |
|
|
|
| GC30554-100mg |
|
108-53-2 |
|
0 |
C4H5N3O |
|
|
|
| GC30553-5mg |
|
115532-49-5 |
|
0 |
C25H25N2O3 |
|
|
|
| GC30552-10mM(1mLinDMSO) |
|
28940-11-6 |
Watermelon ketone (7-Methyl-2H-1,5-benzodioxepin-3(4H)-one)
|
0 |
C10H10O3 |
|
|
|
| GC30551-10mg |
|
58100-03-1 |
|
0 |
C85H113N19O21S2 |
|
|
|
